RYNEX PE
NDC 0485-0202, BROMPHENIRAMINE MALEATE and Phenylephrine HCL, liquid, from EDWARDS PHARMACEUTICALS, INC..
- Product NDC
- 0485-0202
- Status
- Listed
- Labeler
- EDWARDS PHARMACEUTICALS, INC.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0485-0202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BROMPHENIRAMINE MALEATE1 mg/5mL
- PHENYLEPHRINE HYDROCHLORIDE2.5 mg/5mL
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0485-0202-16 | 00485020216 | 473 mL in 1 BOTTLE, PLASTIC (0485-0202-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 00485020216
GET /v1/drugs/nadac/00485020216
Use it
Look up 0485-0202 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0485-0202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0485-0202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.